Skip to main content

Table 1 Characteristics of patients with CC398 Bone and joint infections

From: Epidemiology and risk factors of Staphylococcus aureus CC398 bone and joint infections

 

CC 398 (n = 124)

Non CC 398 (n = 834)

Univariate P value

Age (years), mean ± SD

62.2 (±18.6)

64.3 (±18.7)

0.24

Male sex, n (%)

91 (73)

573 (69)

0.34

Mc Cabe Score

 Non fatal, n (%)

110 (88.7)

761 (91.2)

0.19

 Ultimately fatal, n (%)

13 (10.5)

63 (7.6)

 

 Rapidly fatal, n (%)

1 (0.8)

10 (1.2)

 

MSSA, n (%)

120 (97)

701 (84)

< 0.001

Charlson’s comorbidity score, mean ± SD

2.46 (±2.22)

2.08 (±1.94)

0.073

Year of infection

 2010

4 (3.2)

89 (11)

< 0.001

 2011

2 (1.6)

100 (12)

 

 2012

4 (3.2)

92 (11)

 

 2013

15 (12)

88 (11)

 

 2014

20 (16)

118 (14)

 

 2015

18 (15)

120 (14)

 

 2016

26 (21)

126 (15)

 

 2017

35 (28)

101 (12)

 

Recent hospitalisation (< 1 yr), n (%)

62 (50)

474 (57)

0.18

Surgery (< 1 yr), n (%)

68 (55)

428 (51)

0.53

BJI Type

 Arthritis, n (%)

8 (6.5)

47 (5.6)

0.87

 Osteomyelitis, n (%)

15 (12,1)

119 (14.3)

0.52

 Vertebral osteomyelitis, n (%)

0

6 (0.7)

1

 Diabetic foot osteomyelitis, n (%)

37 (29.8)

207 (24.8)

0.28

 BJI related to decubitus ulcer, n (%)

4 (3.2)

40 (4.8)

0.58

 BJI related to peripheral vascular disease

7 (5.7)

101 (12.1)

0.05

 Orthopaedic device infection, n (%)

53 (42.7)

314 (37.7)

0.31

  including PJI, n (%)

23 (18.6)

121 (14.5)

0.3

  including osteosynthesis infection, n (%)

29 (23.4)

184 (22.1)

0.83

  including vertebral ODI, n (%)

1 (0.8)

9 (1.1)

1

BJI characteristics

 Evolution delay (months)

28 (±62.9)

37.6 (±101.7)

0.32

 Chronic BJI (i.e. evolution delay > 4 weeks), n (%)

49 (75)

270 (68)

0.29

 Bacteremiae, n (%)

20 (16)

87 (10)

0.084

BJI mechanisms

 Haematogenous, n (%)

4 (3.2)

49 (5.9)

0.32

 Inoculation, n (%)

62 (50)

369 (44)

0.27

 Contiguity, n (%)

58 (47)

416 (50)

0.58